Debevoise & Plimpton LLP is advising Carlyle (NASDAQ: CG) in its acquisition of Abingworth, a life sciences investment firm. The transaction will enable Carlyle to operate across the full risk-return spectrum of life sciences and healthcare investing. For more information, please see the company’s press release.
Abingworth is a transatlantic life sciences investment firm with over $2 billion in assets under management (AUM).
The Debevoise team is led by M&A partners Geoffrey Burgess, Jennifer Chu and Kevin Rinker and counsel David Iozzi and includes counsel Andrew Rearick, associates Kay Hunter, Hannah Lee and Guy Polani and law clerk Keith Stackhouse, benefits partner Lawrence Cagney and associate Sandy De Sousa, tax partner Peter Schuur, counsel Jennifer Wheater and associates Christopher Gossage and Robert Nelson-Sullivan, investment management partner Marc Ponchione and associate Sasha Burger, intellectual property counsel Caroline Geiger, associate Melody Godbolt and law clerk Moses Kim and regulatory counsel John Young.